U.S., May 19 -- ClinicalTrials.gov registry received information related to the study (NCT07592104) titled 'Effectiveness on Sino-Nasal Symptoms Of Mepolizumab 300' on Aug. 25, 2025.
Brief Summary: OBJECTIVES The primary objective of this study is evaluating the reduction of dimension of nasal polyps measured with Nasal Polyp Endoscopic Score (NPS) The secondary objective is to evaluate the improvement in nasal symptoms and quality of life in the patient measured through symptom questionnaires, the improvements in terms of smell dysfunction and symptomatology related to eosinophilic otitis media;evaluate the need of surgery or systemic corticosteroids.
ENDPOINTS Primary endpoint The primary endpoints will be the Improvement of NPS score (...